Moreover, they also found that, when combined with anti-VEGFR-2 antibodies, the anti-PD-L1 antibodies can promote normalized vessel formation mediated by CD4+ T cells, which decreases hypoxia in HCC (62) (Figure 2). The gene discussed is KDR; the disease is hepatocellular carcinoma.